Celldex Therapeutics: A 44.6% Better Bargain Than When Ellberger Bought

There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 25, Celldex Therapeutics, Inc.'s Director, Larry Ellberger, invested $70,000.00 into 5,000 shares of CLDX, for a cost per share of $14.00..